Literature DB >> 20085693

Preliminary case report of fatal anthrax in an injecting drug user in North-Rhine-Westphalia, Germany, December 2009.

D Radun1, H Bernard, M Altmann, I Schöneberg, V Bochat, U van Treeck, R M Rippe, R Grunow, M Elschner, W Biederbick, G Krause.   

Abstract

A fatal case of anthrax occurred in an injecting drug user in Germany, in December 2009. A potential link to similar cases in Scotland in the same time period is currently under investigation.

Entities:  

Mesh：

Year:  2010        PMID： 20085693     DOI： 10.2807/ese.15.02.19464-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  9 in total

1.  A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation.

Authors:  Vivian D Hope; Norah Palmateer; Lucas Wiessing; Andrea Marongiu; Joanne White; Fortune Ncube; David Goldberg
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

Review 2.  Anthrax infection.

Authors:  Daniel A Sweeney; Caitlin W Hicks; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Am J Respir Crit Care Med       Date:  2011-08-18       Impact factor: 21.405

Review 3.  An overview of anthrax infection including the recently identified form of disease in injection drug users.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2012-04-24       Impact factor: 17.440

4.  The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax.

Authors:  Kenneth Mark Coggeshall; Florea Lupu; Jimmy Ballard; Jordan P Metcalf; Judith A James; Darise Farris; Shinichiro Kurosawa
Journal:  J Cell Mol Med       Date:  2013-06-07       Impact factor: 5.310

5.  Lessons for control of heroin-associated anthrax in Europe from 2009-2010 outbreak case studies, London, UK.

Authors:  Aula Abbara; Tim Brooks; Graham P Taylor; Marianne Nolan; Hugo Donaldson; Maribel Manikon; Alison Holmes
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

Review 6.  Benefits of a European project on diagnostics of highly pathogenic agents and assessment of potential "dual use" issues.

Authors:  Roland Grunow; G Ippolito; D Jacob; U Sauer; A Rohleder; A Di Caro; R Iacovino
Journal:  Front Public Health       Date:  2014-11-11

Review 7.  Alternative pre-approved and novel therapies for the treatment of anthrax.

Authors:  Breanne M Head; Ethan Rubinstein; Adrienne F A Meyers
Journal:  BMC Infect Dis       Date:  2016-11-03       Impact factor: 3.090

8.  Molecular epidemiologic investigation of an anthrax outbreak among heroin users, Europe.

Authors:  Erin P Price; Meagan L Seymour; Derek S Sarovich; Jennie Latham; Spenser R Wolken; Joanne Mason; Gemma Vincent; Kevin P Drees; Stephen M Beckstrom-Sternberg; Adam M Phillippy; Sergey Koren; Richard T Okinaka; Wai-Kwan Chung; James M Schupp; David M Wagner; Richard Vipond; Jeffrey T Foster; Nicholas H Bergman; James Burans; Talima Pearson; Tim Brooks; Paul Keim
Journal:  Emerg Infect Dis       Date:  2012-08       Impact factor: 6.883

9.  Injectional anthrax at a Scottish district general hospital.

Authors:  D J Inverarity; V M Forrester; J G R Cumming; P J Paterson; R J Campbell; T J G Brooks; G L Carson; J P Ruddy
Journal:  Epidemiol Infect       Date:  2014-07-31       Impact factor: 4.434
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.